Analysis

Ozempic confusion putting travel insurance at risk for thousands

By 2025-09-09T07:00:00

Screenshot 2025-09-04 144849

‘This confusion isn’t academic, it has real consequences for millions of Britons purchasing travel and health insurance,’ says chief executive

Thousands of travel insurance customers may be unaware that their weight loss treatment can be counted as medication for a pre-existing condition – an oversight which has the potential to lead to misrepresentation and the possible voiding of their cover.

Read more…

Explore more personal lines related content here, or discover more news analysis stories here

You need to register to continue reading the rest of this article and more for free.
(If you’re already registered, please sign in here.)

REGISTER NOW FOR FREE

We’re glad you’ve chosen Insurance Times as your source for industry news and hope you’ve been enjoying reading articles from our award-winning team of journalists.

Gain access to more of our exclusive, breaking stories, interviews and news analysis as it happens. Registering is quick, easy, free, and will also have the additional benefits:

  • Uncover Secrets: Dive deep with exclusive annual reports, fueled by expert insights.
  • News That Matters: Award-winning coverage & analysis, delivered to your inbox.
  • Stay Ahead, Your Way: Daily or weekly - choose your news rhythm.
  • Own Your Learning: Curate your knowledge with a personalized library.

Register for FREE now and Keep Reading

Stay on top of the insurance game with our subscription! Get unlimited access to over 80,000 articles, in-depth analysis, exclusive reports by industry experts, and our Five-Star rating system to compare companies and find the best fit for your business needs - view subscription options.